GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.

In a US cohort study, hospital inpatient diversity was linked to improved gastrointestinal outcomes in Hispanic and Native American patients.

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara (ustekinumab).

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right ...

Sarcopenia in the United States appears to be correlated to gallstone risk, most significantly among women, according to study results published in BMC Gastroenterology.